ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Nxera Pharma Co., Ltd. ?
1
Poor Management Efficiency with a low ROE of 1.54%
- The company has been able to generate a Return on Equity (avg) of 1.54% signifying low profitability per unit of shareholders funds
2
Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -1.07
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -1.07
- The company has been able to generate a Return on Equity (avg) of 1.54% signifying low profitability per unit of shareholders funds
3
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 1.54%
4
Flat results in Jun 26
- NET PROFIT(9M) At JPY -6,130 MM has Grown at -37.08%
- INTEREST(Q) At JPY 485 MM has Grown at 68.99%
- RAW MATERIAL COST(Y) Grown by 8.14% (YoY)
5
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -1.25%, its profits have fallen by -330.6%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Nxera Pharma Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Nxera Pharma Co., Ltd.
4.87%
71.45
50.18%
Japan Nikkei 225
60.14%
2.04
29.37%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
30.96%
EBIT Growth (5y)
-281.01%
EBIT to Interest (avg)
-1.16
Debt to EBITDA (avg)
6.40
Net Debt to Equity (avg)
0.43
Sales to Capital Employed (avg)
0.21
Tax Ratio
2.33%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.44%
ROE (avg)
1.54%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.41
EV to EBIT
-57.94
EV to EBITDA
61.29
EV to Capital Employed
1.25
EV to Sales
3.82
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-2.15%
ROE (Latest)
-15.67%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Sideways
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend13What is working for the Company
OPERATING CASH FLOW(Y)
Highest at JPY 874 MM
NET SALES(HY)
At JPY 18,910 MM has Grown at 25.28%
NET PROFIT(Q)
At JPY -202 MM has Grown at 91.5%
-12What is not working for the Company
NET PROFIT(9M)
At JPY -6,130 MM has Grown at -37.08%
INTEREST(Q)
At JPY 485 MM has Grown at 68.99%
RAW MATERIAL COST(Y)
Grown by 8.14% (YoY
CASH AND EQV(HY)
Lowest at JPY 29,345 MM
NET SALES(Q)
Fallen at -9.42%
Here's what is working for Nxera Pharma Co., Ltd.
Operating Cash Flow
Highest at JPY 874 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (JPY MM)
Net Profit
At JPY -202 MM has Grown at 91.5%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (JPY MM)
Here's what is not working for Nxera Pharma Co., Ltd.
Interest
At JPY 485 MM has Grown at 68.99%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (JPY MM)
Net Sales
Fallen at -9.42%
Year on Year (YoY)MOJO Watch
Near term sales trend is negative
Net Sales (JPY MM)
Cash and Eqv
Lowest at JPY 29,345 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Raw Material Cost
Grown by 8.14% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
